Live: One Dial-in One Attendee
Corporate Live: Any number of participants
Recorded: Access recorded version, only for one participant unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
Corporate Recorded: Access recorded version, Any number of participants unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
FDA import operations have changed. Some will be temporary and some will be permanent.
The chain of events from the source of a product all the way to the final user or consignee must be reassessed and updated. As traumatic as the current circumstance is, you not only need to assess how you will cope with the current new risks, but how will you deal with this kind of scenario in the future with a different reason for alarm.
The webinar will walk you through risk factors you should consider. This is not only for protecting the value of your imported products, but the safety of the people involved from the beginning to the end.
The COVID-19 creates a global bondage on commerce and drains, if not dries up, the supply of necessary products to protect the health and welfare of your customer base, which actually is the entire U.S. population.
In this webinar, you will mentally travel through your import process, how it will or can be derailed and identify issues you need to evaluate during the current interruption of your standard import business.
Why should you Attend: What are your new risks and how can you mitigate their impact? What you do not know and do not mitigate as a risk factor will hurt, if not cripple, your near-term global import operations and recovery resilience.
If you do not have an emergency plan in place, you should establish and implement it immediately. You should plan on FDA's revising its import program, information requirements, foreign operations and risk management requirements in the U.S. The risks extend to your foreign manufacturer; port of loading; method and means on conveyance; management of your U.S. port of arrival; and U.S. distribution practices.
In each case, it will cost you more money if you have not planned to mitigate untoward barriers. You will have new problems with other federal agencies with overlapping jurisdiction. Your risk mitigation strategy needs to address a more complex maze of import operation and it must include partner government agencies, e.g.,Customs and Border Patrol Protection, U.S. Coast Guard, USDA, EPA and perhaps new entry requirements by state and local authorities. For example, how will you handle a quarantine of people on the ship that brought your product to the U.S. shore?
Areas Covered in the Session: